Nebojša Arsenijević
Biographic Data
| ID | 7654587 |
|---|---|
| NAME | Nebojša Arsenijević |
| GIVEN NAMES | Nebojša |
| FAMILY NAME | Arsenijević |
| SIGNATURE | ARSENIJEVIĆ N |
| AFFILIATIONS | University of Kragujevac |
| ORCID | 0000-0002-2107-3490 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia
Uric acid (UA) has been shown to have neuroprotective or neurotoxic properties, in relation to specific tissues and diseases that have been studied. Previous studies provided contradictory results on the role of UA in schizophrenia as a neurodegenerative disorder. The aim of this brief report was an additional analysis of UA sera levels in different phases of schizophrenia. Here, 86 patients with first-episode psychosis (FEP) vs. 45 patients with…
Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia
Patients on risperidone and clozapine therapy may be at greater risk of developing metabolic syndrome than patients treated with aripiprazole. Statistically significant difference in concentration of TNF-α and TGF-β was in the group of patients treated with risperidone compared to healthy control group
Chlorpromazine as a Potential Antipsychotic Choice in Covid-19 Treatment
OPINION article Front. Psychiatry, 23 December 2020Sec. Psychopharmacology Volume 11 - 2020 | https://doi.org/10.3389/fpsyt.2020.612347
IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis
Schizophrenia and treatment of this disorder are often accompanied with metabolic syndrome and cardiovascular issues. Alterations in the serum level of innate immune mediators, such as interleukin-33 (IL-33) and its receptor IL-33R (ST2) and Galectin-3 (Gal-3) were observed in these conditions. Moreover, these parameters are potential prognostic and therapeutic markers. There is also accumulating evidence that these molecules play a role in neuro…
No prominent works on this page.
IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis
Schizophrenia and treatment of this disorder are often accompanied with metabolic syndrome and cardiovascular issues. Alterations in the serum level of innate immune mediators, such as interleukin-33 (IL-33) and its receptor IL-33R (ST2) and Galectin-3 (Gal-3) were observed in these conditions. Moreover, these parameters are potential prognostic and therapeutic markers. There is also accumulating evidence that these molecules play a role in neuro…
Chlorpromazine as a Potential Antipsychotic Choice in Covid-19 Treatment
OPINION article Front. Psychiatry, 23 December 2020Sec. Psychopharmacology Volume 11 - 2020 | https://doi.org/10.3389/fpsyt.2020.612347
Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia
Uric acid (UA) has been shown to have neuroprotective or neurotoxic properties, in relation to specific tissues and diseases that have been studied. Previous studies provided contradictory results on the role of UA in schizophrenia as a neurodegenerative disorder. The aim of this brief report was an additional analysis of UA sera levels in different phases of schizophrenia. Here, 86 patients with first-episode psychosis (FEP) vs. 45 patients with…
Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia
Patients on risperidone and clozapine therapy may be at greater risk of developing metabolic syndrome than patients treated with aripiprazole. Statistically significant difference in concentration of TNF-α and TGF-β was in the group of patients treated with risperidone compared to healthy control group
Internal Medicine (4 works) · Medicine (4 works) · Psychiatry (4 works) · Schizophrenia (object-oriented programming (4 works) · Antipsychotic (3 works) · Psychosis (3 works) · Tryptophan and brain disorders (3 works) · Psychology (2 works) · Schizophrenia research and treatment (2 works) · 2019-20 coronavirus outbreak (1 works)